Blog

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Photo taken from Amy C. Moore/LinkedIn

Jun 13, 2024, 10:46

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post on LinkedIn:

“It has been 20 years since the discovery of the EGFR mutation ushered in the era of precision medicine for lung cancer. We are celebrating this important milestone and many more research advances at this year’s LUNGevity Foundation International Lung Cancer Survivorship Conference (ILCSC24), happening virtually Sept 20 – 21. Sign up to get notified when registration opens”

Read further.
Source: Amy C. Moore/LinkedIn

Amy C. Moore cancer EGFR-mutation ILCSC24 International Lung Cancer Survivorship Conference lung cancer research LUNGevity Foundation OncoDaily Oncology Precision Medicine registration notification research advances survivorship virtual conference

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage